Plunkett Research Online: Proteo, Inc.

PROTEO, INC. (PTEO:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Proteo Inc is a clinical stage drug development company. The Company is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases......



Proteo, Inc.
Ticker: PTEO
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 949 253-4616
Fax:
Address: 2102 Business Center Drive
Irvine, CA 92612 United States

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Birge BargmannCEO/CEO, Subsidiary/CFO/CFO, Subsidiary/Director/President
Hartmut WeigeltDirector
See More
Proteo Inc is a clinical stage drug development company. The Company is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases......See More See More

Auditor: SQUAR MILNER LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: